Novel roles for Slits and netrins: axon guidance cues as anticancer targets?

Patrick Mehlen1, Céline Delloye-Bourgeois, Alain Chédotal

  • 1Apoptosis, Cancer and Development Laboratory-Equipe labellisée La Ligue-, CRCL UMR INSERM U1052 CNRS 5286, Université de Lyon, Centre Léon Bérard, 69008 Lyon, France. mehlen@lyon.fnclcc.fr

Nature Reviews. Cancer
|February 18, 2011
PubMed

Insights

Embryogenesis genes like Netrins and Slits regulate tumor development by bypassing safeguards. Deregulated expression in cancers suggests their potential as tumor suppressors or oncogenes and targets for cancer therapy.

Area of Science:

  • Developmental Biology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Genes crucial for embryogenesis can influence tumor progression by overcoming anti-tumor mechanisms.
  • Axon guidance cues, including Netrins and Slits, are implicated in cancer development.

Purpose of the Study:

  • To explore the role of Netrins and Slits in tumor development and progression.
  • To investigate the potential of Netrin-receptor and Slit-receptor interactions as therapeutic targets in cancer.

Main Methods:

  • Analysis of gene and protein expression in human cancers.
  • Review of existing literature on Netrin/Slit signaling in embryogenesis and cancer.

Main Results:

  • Netrin 1 binds to deleted in colorectal cancer (DCC) and UNC5 receptors.
  • Slit proteins bind to roundabout receptors (Robos).
  • Expression of Netrins and Slits is frequently deregulated in various human cancers.

Conclusions:

  • Netrins and Slits can act as oncogenes or tumor suppressors.
  • These ligand-receptor pairs represent promising targets for developing personalized anti-cancer therapies.

Related Concept Videos

Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...